Newsquawk Logo

European Equity pre-Market Summary - 17th September 2026: European equity futures are indicative of a slightly firmer open; Bilfinger sinks after cutting guidance

Daily pre-market roundups of this kind aggregate overnight catalysts rather than set them; the tradeable content is in the single-name idiosyncrasies, not the index indication, which is typically a soft echo of the prior US close and overnight futures.

Newsquawk StaffPublished On the live feed at — 2 more headlines followed before this page went public
Newsquawk headlinesUTC

Apollo (APO) is reportedly raising its SoftBank (9984 JT) loan to USD 9bln for OpenAI bet, Bloomberg reports

Japan Banking Lobby chief Fujiwara says JGB yields are likely to rise further

European Equity pre-Market Summary - 17th September 2026: European equity futures are indicative of a slightly firmer open; Bilfinger sinks after cutting guidance

Japan and the US are reportedly discussing the construction of a semiconductor factory as part of the USD 550bln US investment package agreed during tariff negotiations, Nikkei reports

Germany's VDMA expects 2026 production to decline by 2% in real terms, compared with its previous forecast for no growth

Open the platform and use it. The whole workspace is free to try, with no signup and no card. When you want the headlines arriving live instead of on a delay, Newsquawk Pro is £24.99 for 7 days.

Try the platform free
Free. No signup, no card.

Stories:

Anglo American (AAL LN): The European Commission warned MMG’s proposed acquisition of Anglo American’s Brazilian nickel business could reduce competition and raise European stainless-steel costs. Raiffeisen Bank (RBI AV), -3.2%: Grizzly Research is short Raiffeisen Bank, stating that they have uncovered USD 1.191bln in Russian trade. Novartis (NOVN SW), +1%: Co. discontinued development of VHB937 in ALS following results from the phase 2 Astrals study, which did not meet its primary or secondary endpoints. Roche (ROP SW), +0.7%: Co. announces that the phase 3 CELESTIMO study, met its primary endpoint.

Earnings:

Bollore (BOL FP): In its H1’26 report, Revenue rose from the prior, whilst Net Income fell short. Bilfinger (GBF GY), -9.5%: Co. cuts its FY26 outlook; now sees revenue EUR 5.3-5.7bln (prev. guided EUR 5.4-5.9bln)

IPO:

German Defence: KNDS is reportedly considering pushing back its IPO, as advisors point to the recent stock market performance of listed defence companies, Bloomberg reports.

Broker Moves:

Dassault Systemes (DSY FP) downgraded to Underperform from Neutral at BNP Paribas

The numbers after the Co. & ticker are the pre-market indication via Tradegate

Context

The standouts follow familiar patterns: a guidance cut of the Bilfinger type, where a lowered revenue corridor is the first revision, tends to invite estimate resets over the following sessions, with industrials peers read-across limited unless the cut is demand-driven rather than company-specific. Short-seller reports against banks, as with the Raiffeisen note, have historically produced a sharp initial gap followed by a contested phase in which the lender's response and any regulator or auditor comment determine whether the move sticks; exposure claims of that kind invite scrutiny of disclosures rather than instant re-rating. The European Commission's objection to a metals disposal is the standard second-phase merger review posture and more often ends in remedies than prohibition, while trial readouts in pharma, one failure and one success here, are binary by construction and rarely contaminate the sector beyond the names involved. The follow-ons are the company responses, any formal statement of objections in the nickel case, and whether the defence IPO delay signals broader issuance fatigue in that cohort.

Related headlines

The whole workspace, free to try.

Try it free
Newsquawk Logo

© 2026 Newsquawk. All rights reserved.